Researchers pave the way for improving treatment for Type 2 diabetes

February 7, 2012, University of Montreal

In a study published last week in the prestigious Proceedings of the National Academy of Sciences of the United States of America, a team led by Dr. Vincent Poitout of the University of Montreal Hospital Research Centre (CRCHUM)* has made an important step forward in understanding how insulin secretion is regulated in the body. This discovery has important implications for drugs currently in development to treat Type 2 diabetes, a disease which is diagnosed every 10 seconds somewhere throughout the world.

Poitout's team studies the G protein-coupled free fatty acid receptor (FFA1/GPR40), a molecule that plays a key role in stimulating and regulating the production of insulin, a hormone produced by the pancreas to remove excess glucose from the blood, which otherwise would be toxic.

Poitout's team demonstrated that glucose in the blood stimulates the expression of the receptor, which in turn prompts the body to produce insulin when glucose and rise in the circulation, such as occurs after a meal. Their accomplishment consists in mapping the intricate pathway taken by glucose to stimulate the expression of the receptor and in identifying the various genetic and cellular processes which are activated in this process. This phenomenon contributes to maintaining the right balance between the intake of nutrients and the production of insulin. That balance is precisely what is upset in patients, for whom the production of insulin is deficient, and which leads to a variety of chronic conditions.

Although a new generation of antidiabetic drugs which target this receptor to promote insulin tolerance and production is currently being tested, until now little has been known about precisely how the expression of GPR40 is controlled. "Our work has contributed to a better understanding of how these new drugs work. Our ultimate goal is to allow type 2 to lead a healthy life free from the many complications associated with this disease," explains Poitout.

Type 2 diabetes, which used to occur as people grew older, now appears at a younger age due to the increasing prevalence of obesity in children and adolescents. Its appearance can be hastened by an unhealthy lifestyle (fat-rich diet, lack of exercise, etc.). Although it can sometimes be controlled by adopting a healthier lifestyle and diet, most patients are required to take daily medication for the rest of their lives. The prevalence of diabetes is expected by the World Health Organization to exceed 550 million people by 2030.

Explore further: Saturated fatty acids lead to mitochondrial dysfunction and insulin resistance

Related Stories

Saturated fatty acids lead to mitochondrial dysfunction and insulin resistance

January 20, 2012
Excessive levels of certain saturated fatty acids cause mitochondria to fragment, leading to insulin resistance in skeletal muscle, a precursor of type 2 diabetes, according to a paper in the January issue of the journal ...

Recommended for you

Genetic discovery may help better identify children at risk for type 1 diabetes

January 17, 2018
Six novel chromosomal regions identified by scientists leading a large, prospective study of children at risk for type 1 diabetes will enable the discovery of more genes that cause the disease and more targets for treating ...

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.